Elevated lipoprotein(a) levels in Familial Hypercholesterolaemia (FH): prevalence and implications for FH clinical diagnosis

• A. David,
• Z. Balkhiyarova,
• J. Gihochi-Maina,
• B. Jones,
• I. Prokopenko

Affiliations

A. David

Lipid Clinic, Hammersmith Hospital, Imperial College NHS Trust, London, UK; Centre for Bioinformatics and System Biology, Department of Life Sciences, Imperial College London, London, UK

Z. Balkhiyarova

Section of Statistical Multi-omics, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, United Kingdom; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom; People-centred Artificial Intelligence Institute, University of Surrey, Guildford, UK

J. Gihochi-Maina

EGID, University of Lille, University Hospital, Lille, France

B. Jones

Lipid Clinic, Hammersmith Hospital, Imperial College NHS Trust, London, UK; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom

I. Prokopenko

Section of Statistical Multi-omics, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, United Kingdom; People-centred Artificial Intelligence Institute, University of Surrey, Guildford, UK; EGID, University of Lille, University Hospital, Lille, France